FDA Accelerated Approval Pathways for Cell and Gene Therapy products
The cell and gene therapy regulatory landscape is rapidly evolving. Join this webinar to discover the approaches available to this industry to accelerate the approval of cell and gene therapy products.
sponsored by Thermo Fisher Scientific
June 22, 2020 | 11am EDT / 4pm BST / 5pm CEST
The cell and gene therapy regulatory landscape is rapidly evolving. Join this webinar to discover the approaches available to this industry to accelerate the approval of cell and gene therapy products by discussing early FDA engagement opportunities, identifying the different approval pathways taken by the Agency to bring products to market quickly, and examining the recent cell and gene therapy guidances issued by the FDA.
Learning Objectives
- Cell and gene therapy regulatory landscape.
- The different types of FDA expedited pathways available.
- Recent cell and gene therapy guidances issued.
